MAPT and Alzheimer disease: In conclusion, we have discovered that DNA damage–induced Chk1 activation promotes tau and APP hyperphosphorylation and cognitive dysfunction in AD, and the Chk1-CIP2A-PP2A pathway may be involved in mediating this pathogenesis.